Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 27, 2025 07:30 ET | Source: Pasinex Resources Limited

Pasinex Announces Q2 2025 Financial Results and Provides Corporate Update

TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Pasinex Resources Limited (CSE: PSE) (FSE: PNX) ("Pasinex" or the "Company") today announced financial results for the second quarter ended June 30, 2025....
August 26, 2025 08:00 ET | Source: PharmaTher Holdings Ltd.

PharmaTher Provides Corporate Update Following FDA Approval of Ketamine (KETARx™)

TORONTO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the...
August 15, 2025 07:00 ET | Source: Abaxx Technologies Inc.

Abaxx Provides Q2 2025 Corporate Update

TORONTO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder...
August 14, 2025 08:00 ET | Source: Chemomab Therapeutics

Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Phase 3 preparations are ongoing while Chemomab is advancing partnering options for executing the nebokitug Phase 3 program. Runway through end of Q2 2026.
August 11, 2025 16:52 ET | Source: Anteris Technologies Global Corp.

Anteris Announces Results for the Second Quarter of 2025

Anteris Announces Results for the Second Quarter of 2025
August 06, 2025 07:30 ET | Source: Arbutus Biopharma Corporation

Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Q2 total revenue of $10.7M includes previously-deferred revenue following reacquisition of Greater China rights to imdusiran Dr. Roger Sawhney joins the Arbutus Board of Directors following...
August 05, 2025 07:00 ET | Source: AC Immune SA

AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update Three active immunotherapies for precision prevention of neurodegeneration progressing through Phase 2 clinical...
July 31, 2025 08:00 ET | Source: Reconnaissance Energy Africa Ltd.

ReconAfrica Provides a Corporate Update and Announces That the Kavango West 1X Well Has Started Drilling

CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) -- Reconnaissance Energy Africa Ltd. (the “Company” or “ReconAfrica”) (TSXV: RECO) (OTCQX: RECAF) (Frankfurt: 0XD) (NSX: REC) announces that the...
May 29, 2025 17:05 ET | Source: Kane Biotech Inc.

Kane Biotech Announces First Quarter 2025 Financial Results

WINNIPEG, Manitoba, May 29, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces its first quarter 2025 financial results. First...
May 27, 2025 08:59 ET | Source: NurExone Biologic Inc

NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-stage biotechnology company...